Triumpharma LLC
↗Amman, Jordan (Primary); Mystic, Connecticut, United States (Secondary)
Triumpharma is a full-service Contract Research Organization (CRO) founded in 2002 that specializes in clinical trials and pharmaceutical development services. The company operates state-of-the-art GCP, GLP, and GMP-compliant facilities and provides comprehensive clinical study outsourcing services including Phase I-IV clinical trials, bioanalytical and pathological laboratory testing, clinical data management, statistical analysis, and medical writing. Triumpharma has successfully conducted over 300+ US-FDA submissions, EU/ANSAM/Bfarm/MHRA submissions, and MENA/JFDA submissions across diverse therapeutic areas.
CLASSIFICATION
SIZE & FINANCIALS
Employees:51-200
Revenue:$8.1M (Mystic facility estimate)
Founded:2002
Ownership:private
Status:operating
PIPELINE
Stage:Not Applicable (CRO does not develop its own pipeline)
Lead Drug Stage:N/A
Modalities:Small Molecule, Biologics, Controlled Release Formulations, Drug Delivery Systems
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Multinational pharmaceutical companies globally, Merck, Glaxo Smith Kline, ViiV Healthcare (historical trial partnerships)
COMPETITION
Position:Niche Player - Regional leader in MENA region with differentiated low-cost base and experienced staff
Competitors:Charles River Laboratories, Parexel, ICON plc, Covance, Other regional CROs in Middle East
LEADERSHIP
Key Executives:
Dr. Ahmad Al-Ghazawi - Founder & CEO
Rana Jaouni - Chief Scientific Officer & QA/Regulatory Affairs Director
Scientific Founders:Dr. Ahmad Al-Ghazawi (Founder with 29+ years pharma experience)
LINKS
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Triumpharma LLC and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Triumpharma LLC. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.